Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xing-Xing Fan

Showing results (41-50 of 77) with videos related to

Pageof 8
Sort By:
Pharmacological Research|June 6, 2022
Bacteria-based nanodrug for anticancer therapyYa-Jia Xie, Min Huang, Dan Li, et al.
Technology in Cancer Research & Treatment|July 10, 2023
Detection of Single Cancer Cell Multidrug Resistance With Single Cell BioanalyzerJun Cai, Xing-Xing Fan, Run-Ze Li, et al.
Current Medical Science|July 16, 2025
Development and Validation of a Nomogram Prediction Model for Sepsis-Induced Coagulopathy: A Multicenter Retrospective StudyWen-Hao Ma, Ze-Yu Yang, Xing-Xing Fan, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 29, 2023
Pharmacokinetics, absorption and transport mechanism for ginseng polysaccharidesJuanhong Zhang, Jiaxin He, Jumin Huang, et al.
Medchemcomm|August 16, 2018
Identification of a potent kinase inhibitor targeting EML4-ALK fusion protein in non-small cell lung cancerLian-Xiang Luo, Ying Li, Yu-Zhen Niu, et al.
Chemical Biology & Drug Design|June 23, 2018
Identification of a new pyruvate kinase M2 isoform (PKM2) activator for the treatment of non-small-cell lung cancer (NSCLC)Run-Ze Li, Xing-Xing Fan, Dan-Feng Shi, et al.
Cancer Cell International|July 31, 2019
p53 sensitizes chemoresistant non-small cell lung cancer via elevation of reactive oxygen species and suppression of EGFR/PI3K/AKT signalingYize Zhang, Chae Young Han, Fu Gang Duan, et al.
Molecules (Basel, Switzerland)|March 22, 2016
Compound Library Screening Identified Cardiac Glycoside Digitoxin as an Effective Growth Inhibitor of Gefitinib-Resistant Non-Small Cell Lung Cancer via Downregulation of α-Tubulin and Inhibition of Microtubule FormationYi-Ze Zhang, Xi Chen, Xing-Xing Fan, et al.
Stem Cell Reviews and Reports|February 3, 2020
Characterization of an Anti-CD5 Directed CAR T-Cell against T-Cell MalignanciesMasayuki Wada, Hongyu Zhang, Liu Fang, et al.
Pharmacological Research|May 29, 2020
Chelidonine selectively inhibits the growth of gefitinib-resistant non-small cell lung cancer cells through the EGFR-AMPK pathwayYa-Jia Xie, Wei-Na Gao, Qi-Biao Wu, et al.
Pageof 8

Showing results (41-50 of 77) with videos related to

Sort By:
Pageof 8
Pharmacological Research|June 6, 2022
Bacteria-based nanodrug for anticancer therapyYa-Jia Xie, Min Huang, Dan Li, et al.
Technology in Cancer Research & Treatment|July 10, 2023
Detection of Single Cancer Cell Multidrug Resistance With Single Cell BioanalyzerJun Cai, Xing-Xing Fan, Run-Ze Li, et al.
Current Medical Science|July 16, 2025
Development and Validation of a Nomogram Prediction Model for Sepsis-Induced Coagulopathy: A Multicenter Retrospective StudyWen-Hao Ma, Ze-Yu Yang, Xing-Xing Fan, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 29, 2023
Pharmacokinetics, absorption and transport mechanism for ginseng polysaccharidesJuanhong Zhang, Jiaxin He, Jumin Huang, et al.
Medchemcomm|August 16, 2018
Identification of a potent kinase inhibitor targeting EML4-ALK fusion protein in non-small cell lung cancerLian-Xiang Luo, Ying Li, Yu-Zhen Niu, et al.
Chemical Biology & Drug Design|June 23, 2018
Identification of a new pyruvate kinase M2 isoform (PKM2) activator for the treatment of non-small-cell lung cancer (NSCLC)Run-Ze Li, Xing-Xing Fan, Dan-Feng Shi, et al.
Cancer Cell International|July 31, 2019
p53 sensitizes chemoresistant non-small cell lung cancer via elevation of reactive oxygen species and suppression of EGFR/PI3K/AKT signalingYize Zhang, Chae Young Han, Fu Gang Duan, et al.
Molecules (Basel, Switzerland)|March 22, 2016
Compound Library Screening Identified Cardiac Glycoside Digitoxin as an Effective Growth Inhibitor of Gefitinib-Resistant Non-Small Cell Lung Cancer via Downregulation of α-Tubulin and Inhibition of Microtubule FormationYi-Ze Zhang, Xi Chen, Xing-Xing Fan, et al.
Stem Cell Reviews and Reports|February 3, 2020
Characterization of an Anti-CD5 Directed CAR T-Cell against T-Cell MalignanciesMasayuki Wada, Hongyu Zhang, Liu Fang, et al.
Pharmacological Research|May 29, 2020
Chelidonine selectively inhibits the growth of gefitinib-resistant non-small cell lung cancer cells through the EGFR-AMPK pathwayYa-Jia Xie, Wei-Na Gao, Qi-Biao Wu, et al.
Pageof 8